Clinical Diagnosis of Multiple Sclerosis

Giang, Daniel W.

doi:10.1001/archneur.1994.00540130087016

Search citation statements

Order By: Relevance

Paper Sections

Select...

Progressive Relapsing Ms (Prms)1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1996

2019

Publication Types

Select...

Book4

Other1

Article1

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 16 publications

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sensitivity of MRIs in detecting MS varies from 81-90%. 6,7 Treatments: Currently, there is no known cure for MS. Disease modifying agents are used to prolong demyelination and slow down disease progression. All disease-modifying agents are approved for RRMS and only Mitroxantone is approved for secondary progressive MS ( Table 1).…”

Section: Progressive Relapsing Ms (Prms)mentioning

confidence: 99%

Untitled

2019

MOJPH

View full text Add to dashboard Cite

140 years later, there is still no known cause, nor cure, for the disease. Treatments to slow progression are available and may help with functioning. Onset of MS remains unclear, however, it is now recognized that MS can arise during childhood or adolescence. 3 MS affects roughly 2.1 million people worldwide with wide geographic variation. In general, observed prevalence is greater at higher latitudes with exceptions (i.e. low rates observed among Chinese, Japanese and Africans; high rates observed among Sardinians, Iranians and Palestinians). 4,5 Diagnoses and treatments: Patients may present with a range of symptoms from cognitive changes to ataxia, depression, visual impairments or hemiparesis. Commonly identified symptoms include:

show abstract

Section: Progressive Relapsing Ms (Prms)mentioning

confidence: 99%